Santos, I. and Clissold, S. (2010) Urogenital disorders associated with oestrogen deficiency: The role of promestriene as topical oestrogen therapy. Gynecological Endocrinology, 26, 644-651.
 Bachmann, G.A. and Nevadunsky, N.S. (2000) Diagnosis and treatment of atrophic vaginitis. American Family Physician, 61, 3090-3096.
 Palacios, S. (2009) Managing urogenital atrophy. Mauritas, 63, 315-318. doi:10.1016/j.ma turitas.2009.04.009
 Mac Bride, M.B., Rhodes, D.J. and Shuster, L.T. (2010) Vulvovaginal atrophy. Mayo Clinic Proceedings, 85, 87-94. doi:10.4065/mcp.2009.0413
 Goldstein, I. (2010) Recognizing and treating urogenital atrophy in postmenopausal women. Journal of Women’s Health, 19, 425-432. doi:10.1089/jwh.2009.1384
 Costantino, D. and Guaraldi, C. (2008) Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: An open, non-controlled clinical trial. European Review for Medical and Pharmacological Sciences, 12, 411-416.
 Morali, G., Polatti, F., Metelitsa, E.N., Mascarucci, P., Magnani, P. and Brunenghi Marrè, G. (2006) Open, noncontrolled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy. Arzneimittel Forschung—Drug Research, 56, 230-238.
 Lewis, V. (2009) Undertreatment of menopausal symptoms and novel options for comprehensive management. Current Medical Research and Opinion, 25, 2689-2698.
 Nachtigall, L.E. (1994) Comparative study: Replens versus local estrogen in menopausal women. Fertility and Sterility, 61, 178-180.